Literature DB >> 29132853

Assessing clinical response and defining minimal disease activity in plaque psoriasis with the Physician Global Assessment and body surface area (PGA × BSA) composite tool: An analysis of apremilast phase 3 ESTEEM data.

Alice B Gottlieb1, Joseph F Merola2, Rongdean Chen3, Eugenia Levi3, Kristina Callis Duffin4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29132853     DOI： 10.1016/j.jaad.2017.06.162

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  6 in total

1.  Exploration of the Product of the 5-Point Investigator's Global Assessment and Body Surface Area (IGA × BSA) as a Practical Minimal Disease Activity Goal in Patients with Moderate-to-Severe Psoriasis.

Authors:  Alice B Gottlieb; Rebecca Germino; Vivian Herrera; Xiangyi Meng; Joseph F Merola
Journal:  Dermatology       Date:  2019-05-29       Impact factor: 5.366

Review 2.  Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.

Authors:  Emilie Sbidian; Anna Chaimani; Ignacio Garcia-Doval; Liz Doney; Corinna Dressler; Camille Hua; Carolyn Hughes; Luigi Naldi; Sivem Afach; Laurence Le Cleach
Journal:  Cochrane Database Syst Rev       Date:  2022-05-23

3.  Product of Investigator Global Assessment and Body Surface Area (IGAxBSA): A practice-friendly alternative to the Eczema Area and Severity Index to assess atopic dermatitis severity in children.

Authors:  Timothy P Suh; Divya Ramachandran; Vidhi Patel; Kathryn L Jackson; Stephanie M Rangel; Anna B Fishbein; Amy S Paller
Journal:  J Am Acad Dermatol       Date:  2020-01-21       Impact factor: 11.527

4.  Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.

Authors:  Emilie Sbidian; Anna Chaimani; Ignacio Garcia-Doval; Liz Doney; Corinna Dressler; Camille Hua; Carolyn Hughes; Luigi Naldi; Sivem Afach; Laurence Le Cleach
Journal:  Cochrane Database Syst Rev       Date:  2021-04-19

5.  Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.

Authors:  Emilie Sbidian; Anna Chaimani; Sivem Afach; Liz Doney; Corinna Dressler; Camille Hua; Canelle Mazaud; Céline Phan; Carolyn Hughes; Dru Riddle; Luigi Naldi; Ignacio Garcia-Doval; Laurence Le Cleach
Journal:  Cochrane Database Syst Rev       Date:  2020-01-09

6.  Deucravacitinib in Moderate to Severe Psoriasis: Clinical and Quality-of-Life Outcomes in a Phase 2 Trial.

Authors:  Diamant Thaçi; Bruce Strober; Kenneth B Gordon; Peter Foley; Melinda Gooderham; Akimichi Morita; Kim A Papp; Lluís Puig; M Alan Menter; Matthew J Colombo; Yedid Elbez; Renata M Kisa; June Ye; Andrew A Napoli; Lan Wei; Subhashis Banerjee; Joseph F Merola; Alice B Gottlieb
Journal:  Dermatol Ther (Heidelb)       Date:  2022-01-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.